epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Iophen C-NR
    codeine/ guaifenesin
  • remove Jolivette
    norethindrone
  • remove Synjardy XR
    empagliflozin/ metformin

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Iophen C-NR (codeine/ guaifenesin) + Synjardy XR (empagliflozin/ metformin)

Monitor/Modify Tx


codeine + empagliflozin

monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

Smiley face Smiley face Jolivette (norethindrone) + Synjardy XR (empagliflozin/ metformin)

Monitor/Modify Tx


norethindrone (contraceptive) + empagliflozin

monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

norethindrone (contraceptive) + metformin

monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

Additional Considerations

Smiley face Smiley face codeine in Iophen C-NR

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information